NEW YORK (360Dx) – Grifols today announced the US Food and Drug Administration has approved the firm's Erytra Eflexis, a fully automated benchtop analyzer for pretransfusion compatibility testing.

The system leverages Grifols' DG Gel technology and can be used as a standalone platform or in combination with Grifols' other blood typing portfolio solutions, the firm said. It added the system facilitates multiple lab configurations and features real random access with a capacity of up to 200 cares, 72 samples, and 46 liquid reagents.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.